Skip to main content
. Author manuscript; available in PMC: 2019 Sep 19.
Published in final edited form as: Expert Opin Ther Targets. 2017 Mar 17;21(5):485–498. doi: 10.1080/14728222.2017.1306055

Figure 1.

Figure 1.

Network of gp130-interacting signaling pathways. This figure illustrates the network of integral signaling pathways that are aberrantly activated in a variety of cancers, as well as in BTC. Mitogen-activated protein kinases (MAPK), phosphoinositide 3-kinase (PI3K), and Janus kinase/signal transducer and activator of transcription (Jak/STAT) signaling cascades cross talk and contribute to tumor growth, proliferation and treatment resistance.